Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (101-110 of 268) with videos related to

Pageof 27
Sort By:
Canadian Liver Journal|August 22, 2022
Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)Brian Conway, Dan Smyth, Réjean Thomas, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot StudyAlexa Keeshan, Carla Coffin, Alicia Vachon, et al.
Journal of Clinical Immunology|May 15, 2014
High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccineKaren K Yam, Erica Gipson, Marina Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2015
Contribution of Major Metabolites toward Complex Drug-Drug Interactions of Deleobuvir: In Vitro Predictions and In Vivo OutcomesRucha S Sane, Diane Ramsden, John P Sabo, et al.
Canadian Journal of Gastroenterology & Hepatology|November 12, 2013
Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapyCurtis Cooper, Stephan Shafran, Susan Greenbloom, et al.
Canadian Liver Journal|July 18, 2025
Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in CanadaMariam Z El Sheikh, Jim Young, Dimitra Panagiotoglou, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 30, 2016
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentMark Hull, Stephen Shafran, Alex Wong, et al.
AIDS Patient Care and Stds|May 9, 2013
Gender disparities in HIV risk behavior and access to health care in St. Petersburg, RussiaColins Vasquez, Dmitry Lioznov, Svetlana Nikolaenko, et al.
BMC Infectious Diseases|January 19, 2017
Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort studyValérie Martel-Laferrière, Roy Nitulescu, Joseph Cox, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|November 11, 2024
Locally acquired typhoid fever outbreak linked to chronic carriage in Ottawa, Canada, 2018-2022Janice Zhang, Ann Jolly, Tram Nguyen, et al.
Pageof 27

Showing results (101-110 of 268) with videos related to

Sort By:
Pageof 27
Canadian Liver Journal|August 22, 2022
Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)Brian Conway, Dan Smyth, Réjean Thomas, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot StudyAlexa Keeshan, Carla Coffin, Alicia Vachon, et al.
Journal of Clinical Immunology|May 15, 2014
High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccineKaren K Yam, Erica Gipson, Marina Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2015
Contribution of Major Metabolites toward Complex Drug-Drug Interactions of Deleobuvir: In Vitro Predictions and In Vivo OutcomesRucha S Sane, Diane Ramsden, John P Sabo, et al.
Canadian Journal of Gastroenterology & Hepatology|November 12, 2013
Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapyCurtis Cooper, Stephan Shafran, Susan Greenbloom, et al.
Canadian Liver Journal|July 18, 2025
Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in CanadaMariam Z El Sheikh, Jim Young, Dimitra Panagiotoglou, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 30, 2016
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentMark Hull, Stephen Shafran, Alex Wong, et al.
AIDS Patient Care and Stds|May 9, 2013
Gender disparities in HIV risk behavior and access to health care in St. Petersburg, RussiaColins Vasquez, Dmitry Lioznov, Svetlana Nikolaenko, et al.
BMC Infectious Diseases|January 19, 2017
Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort studyValérie Martel-Laferrière, Roy Nitulescu, Joseph Cox, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|November 11, 2024
Locally acquired typhoid fever outbreak linked to chronic carriage in Ottawa, Canada, 2018-2022Janice Zhang, Ann Jolly, Tram Nguyen, et al.
Pageof 27